Form 4: Camp4 Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Daniel Tardiff, Chief Scientific Officer of Camp4 Therapeutics Corp, sold 1,738 shares of common stock on August 19, 2026 for $4.76 per share.
Summary
- Open-market sale: disposed of 1,738 Common Stock at $4.76 ($8,273) on August 19, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $8,273 of stock on the open market.
Insider Transactions
Daniel Tardiff — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Open-market sale | Common Stock | 1,738 | $5 | $8.3K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Open-market sale (1,738 shares) |
Keywords
insider transaction, Form 4, CAMP, Camp4 Therapeutics Corp, bearish, Daniel Tardiff
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.